Table 4.
Baseline characteristics of grass and olive allergy.
| Clinical and demographic characteristics | All patients n = 341 (%) | |||
|---|---|---|---|---|
| Gender | ||||
| Male | 159 (46.6) | |||
| Female | 182 (53.4) | |||
| Skin tests | ||||
| Grass positive | 301 (94.7) | |||
| Olive positive | 309 (96.9) | |||
| Profilin positive | 91 (29.1) | |||
| Polcalcin positive | 65 (23.8) | |||
| Allergy symptoms | ||||
| Rhinoconjunctivitis | ||||
| No | 9 (2.6) | |||
| Mild | 153 (44.9) | |||
| Moderate/severe | 179 (52.5) | |||
| Asthma | ||||
| No | 38 (11.1) | |||
| Mild | 174 (51.0) | |||
| Moderate/severe | 129 (37.8) | |||
| Immunotherapy | ||||
| No | 271 (79.9) | |||
| Grass and olive immunotherapy | 58 (17.1) | |||
| Only olive immunotherapy | 10 (3.0) | |||
| Only grass immunotherapy | 0 (0.0) | |||
| Mean | Median | SD* | IQR† | |
| Age | 24.3 | 23.0 | 12.3 | 15–32.3 |
| Total IgE (kU/L) | 604.6 | 323.3 | 726.6 | 145.0–787.0 |
| Lolium sIgE‡(kUA/L) | 41.0 | 14.7 | 74.7 | 6.1–41.6 |
| rPhl p 1,5 sIgE (kUA/L) | 28.5 | 10.7 | 51.5 | 3.8–29.4 |
| Olea sIgE (kUA/L) | 84.1 | 30.4 | 145.2 | 8.2–84.3 |
| Ole e 1 sIgE (kUA/L) | 43.4 | 11.4 | 89.1 | 2.9–43.1 |
| Ole e 7 sIgE (kUA/L) | 31.1 | 0.9 | 72.1 | 0.2–22.4 |
| Ole e 9 sIgE (kUA/L) | 20.8 | 0.2 | 48.1 | 0.0–15.9 |
SD*, standard deviation; IQR†, interquartile range; sIgE‡, specific Immunoglobulin E.